Stock listing
gettex:38I Intellia Therapeutics, Inc. Aktie
German listing (gettex) of Intellia Therapeutics, Inc. · home listing NASDAQ:NTLA
Follow Intellia Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:NTLA
$11.66 USD -0.81 (-6.5%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:NTLA
- Day range
- $11.60 – $12.61 USDNov 2, 2026
- Volume
- 3.88M sharesNov 2, 2026
- Market cap
- $1.63B USDAt the close on Nov 2, 2026 · price × 140.1M shares outstanding
- 52-week range
- $7.95 – $18.48 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $53.19M USDMedian day 3.92M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NTLA · Home | $11.66 USD | -0.81 (-6.5%) | 3,877,651 | $12.60 | $12.61 | $11.60 | $12.47 | Close on Nov 2, 2026 |
| LSE:0JBU | $12.15 USD | +1.10 (+10.0%) | 26,687 | $11.28 | $12.19 | $11.13 | $11.05 | Close on Oct 27, 2026 |
| Frankfurt:38I | €11.80 EUR | +2.14 (+22.2%) | — | €11.30 | €11.80 | €11.30 | €9.66 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:NTLA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $11.66 | -0.81 | -6.5% | $12.60 | $12.61 | $11.60 | 3,877,651 | |
| $12.47 | -0.76 | -5.7% | $12.82 | $13.13 | $12.04 | 4,073,177 | |
| $13.23 | -0.09 | -0.7% | $13.32 | $13.94 | $12.92 | 4,686,395 | |
| $13.32 | +1.04 | +8.5% | $12.04 | $13.34 | $11.93 | 4,896,815 | |
| $12.28 | +1.02 | +9.1% | $11.30 | $12.31 | $11.17 | 3,823,687 | |
| $11.26 | +0.05 | +0.4% | $11.24 | $11.44 | $11.09 | 2,061,619 | |
| $11.21 | +0.05 | +0.4% | $11.00 | $11.24 | $10.58 | 3,564,300 | |
| $11.16 | -0.49 | -4.2% | $11.41 | $11.97 | $10.98 | 3,648,600 | |
| $11.65 | -0.19 | -1.6% | $11.84 | $11.91 | $11.55 | 2,827,600 | |
| $11.84 | +0.26 | +2.2% | $11.46 | $12.00 | $11.29 | 3,413,400 | |
| $11.58 | +0.16 | +1.4% | $11.54 | $11.85 | $11.33 | 3,503,900 | |
| $11.42 | +0.08 | +0.7% | $11.60 | $11.68 | $10.91 | 8,235,600 | |
| $11.34 | -0.09 | -0.8% | $11.33 | $11.83 | $11.10 | 6,519,700 | |
| $11.43 | -0.48 | -4.0% | $11.83 | $11.87 | $11.29 | 5,439,200 | |
| $11.91 | -0.67 | -5.3% | $12.30 | $12.48 | $11.82 | 5,177,200 | |
| $12.58 | -0.49 | -3.7% | $13.08 | $13.23 | $12.57 | 4,380,500 | |
| $13.07 | +0.47 | +3.7% | $12.36 | $13.27 | $11.93 | 8,154,700 | |
| $12.60 | +0.89 | +7.6% | $11.90 | $12.64 | $11.76 | 13,974,100 | |
| $11.71 | -0.66 | -5.3% | $12.08 | $12.41 | $11.70 | 8,298,200 | |
| $12.37 | -0.38 | -3.0% | $12.50 | $13.22 | $12.04 | 7,949,100 | |
| $12.75 | +0.49 | +4.0% | $12.35 | $12.88 | $11.85 | 4,962,800 | |
| $12.26 | +0.14 | +1.2% | $12.42 | $12.77 | $12.10 | 4,501,800 | |
| $12.12 | +0.06 | +0.5% | $11.98 | $12.66 | $11.82 | 7,445,400 | |
| $12.06 | +0.03 | +0.2% | $11.96 | $12.24 | $11.75 | 5,314,800 | |
| $12.03 | +0.61 | +5.3% | $11.49 | $12.05 | $11.42 | 5,014,100 | |
| $11.42 | -0.33 | -2.8% | $11.72 | $11.80 | $11.33 | 3,294,100 | |
| $11.75 | -0.41 | -3.4% | $12.33 | $12.33 | $11.67 | 2,975,900 | |
| $12.16 | -0.17 | -1.4% | $12.13 | $12.21 | $11.62 | 4,807,600 | |
| $12.33 | -0.36 | -2.8% | $12.72 | $12.85 | $11.96 | 5,034,700 | |
| $12.69 | +0.47 | +3.8% | $12.27 | $12.97 | $12.14 | 3,920,500 | |
| $12.22 | +0.08 | +0.7% | $12.50 | $12.65 | $12.14 | 3,732,000 | |
| $12.14 | -0.12 | -1.0% | $12.16 | $12.47 | $11.87 | 8,619,300 | |
| $12.26 | +0.77 | +6.7% | $11.99 | $12.87 | $11.95 | 5,753,200 | |
| $11.49 | +0.13 | +1.1% | $11.46 | $11.75 | $11.37 | 4,586,800 | |
| $11.36 | -0.51 | -4.3% | $11.75 | $11.82 | $11.24 | 3,990,800 | |
| $11.87 | +0.13 | +1.1% | $11.65 | $12.11 | $11.65 | 2,597,100 | |
| $11.74 | -0.19 | -1.6% | $12.10 | $12.19 | $11.69 | 2,707,500 | |
| $11.93 | -0.28 | -2.3% | $11.90 | $11.96 | $11.66 | 3,920,700 | |
| $12.21 | -0.53 | -4.2% | $12.50 | $12.82 | $12.19 | 4,932,200 | |
| $12.74 | 0.00 | 0.0% | $12.83 | $12.89 | $12.43 | 4,130,293 | |
| $12.74 | +0.06 | +0.5% | $12.59 | $12.96 | $12.52 | 2,791,700 | |
| $12.68 | -0.08 | -0.6% | $12.86 | $12.92 | $12.40 | 3,002,200 | |
| $12.76 | +0.075 | +0.6% | $12.67 | $13.13 | $12.28 | 3,244,100 | |
| $12.69 | -0.045 | -0.4% | $12.52 | $12.81 | $12.34 | 2,179,700 | |
| $12.73 | -0.14 | -1.1% | $12.64 | $12.85 | $12.44 | 2,923,100 | |
| $12.87 | -0.24 | -1.8% | $13.11 | $13.49 | $12.68 | 3,437,300 | |
| $13.11 | -0.08 | -0.6% | $13.26 | $13.45 | $13.00 | 2,444,900 | |
| $13.19 | -0.32 | -2.4% | $13.38 | $13.50 | $12.98 | 2,707,200 | |
| $13.51 | +0.95 | +7.6% | $12.84 | $13.73 | $12.76 | 4,091,924 | |
| $12.56 | -0.28 | -2.2% | $12.60 | $12.79 | $12.24 | 3,117,690 | |
| $12.84 | +0.40 | +3.2% | $12.65 | $13.13 | $12.65 | 3,345,900 | |
| $12.44 | -0.84 | -6.3% | $12.95 | $13.04 | $12.29 | 4,703,600 | |
| $13.28 | +1.68 | +14.5% | $12.10 | $13.35 | $12.01 | 6,114,900 | |
| $11.60 | -0.49 | -4.1% | $11.80 | $12.10 | $11.44 | 3,178,600 | |
| $12.09 | +0.18 | +1.5% | $11.91 | $12.22 | $11.75 | 1,818,800 | |
| $11.91 | +0.08 | +0.7% | $11.83 | $12.04 | $11.41 | 2,360,900 | |
| $11.83 | -0.26 | -2.2% | $12.11 | $12.17 | $11.81 | 2,945,800 | |
| $12.09 | +0.07 | +0.6% | $12.06 | $12.31 | $11.88 | 2,042,000 | |
| $12.02 | 0.00 | 0.0% | $11.96 | $12.14 | $11.69 | 2,569,300 | |
| $12.02 | +0.08 | +0.7% | $11.80 | $12.24 | $11.75 | 3,032,400 | |
| $11.94 | +0.70 | +6.2% | $11.88 | $12.08 | $11.47 | 4,937,200 | |
| $11.24 | +0.27 | +2.5% | $10.64 | $11.32 | $10.64 | 4,341,300 | |
| $10.97 | -0.35 | -3.1% | $11.31 | $11.43 | $10.85 | 4,734,400 | |
| $11.32 | +0.55 | +5.1% | $10.98 | $11.34 | $10.76 | 4,339,800 | |
| $10.77 | +0.09 | +0.8% | $10.55 | $10.84 | $10.40 | 3,319,900 |
- Ticker
- gettex:38I
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Nov 3, 2026
Intellia Therapeutics Announces Upcoming Nexiguran Ziclumeran (nex-z) Medical Congress Presentations
Latest earnings call · Aug 6, 2026
Intellia Therapeutics (NASDAQ:NTLA) Q2 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 37 slides
Calls
Replays
Intellia Therapeutics (NASDAQ:NTLA) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 8:00 AM ET
Watch TranscriptIntellia Therapeutics (NASDAQ:NTLA) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 8:00 AM ET
Watch TranscriptIntellia Therapeutics (NASDAQ:NTLA) Q3 2025 Earnings Call
Thu, Nov 06, 2025 · 6:00 PM ET
Watch Transcript
Latest news
Intellia Therapeutics Announces Upcoming Lonvoguran Ziclumeran (Lonvo-z) Investor Event and Seven Presentations at ACAAI 2026
Oct 29, 2026
Closed $13.23 (-0.7%) on Oct 29, 2026
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 28, 2026
Closed $13.23 (-0.7%) on Oct 29, 2026
Intellia Therapeutics Appoints Jing L. Marantz, M.D., Ph.D., as Chief Medical Officer
Oct 13, 2026
Closed $11.91 (-5.3%) on Oct 13, 2026
Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)
Sep 8, 2026
Closed $12.74 (0.0%) on Sep 8, 2026
Intellia Therapeutics Secures Non-Dilutive Debt Facility with OrbiMed for up to $400 Million
Sep 4, 2026
Closed $12.74 (+0.5%) on Sep 4, 2026
Intellia Therapeutics to Present at Morgan Stanley 24th Annual Global Healthcare Conference
Sep 4, 2026
Closed $12.74 (+0.5%) on Sep 4, 2026
Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates
Jul 30, 2026
Closed $11.09 (+2.7%) on Jul 30, 2026
Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
Jun 13, 2026
Closed $14.92 (+23.2%) on Jun 15, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 37 slides · August 2026
Technical Presentation (April 2026)
Technical · 32 slides · Apr 27, 2026
Investor Presentation (January 2026)
Investor deck · 37 slides · Jan 9, 2026
American Heart Association Scientific Sessions 2025 (AHA25)
Conference · 19 slides · November 2025
Intellia Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 28 in the last 12 months · 191 in all · newest Nov 3, 2026 · oldest 2019
- Calls
- 18 calls with a replay · 18 with a transcript · latest Aug 6, 2026
- Decks
- 17 decks · latest August 2026
Where Intellia Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NTLA · Home listing | NASDAQ | United States | USD |
| gettex:38I · This page | gettex | Germany | EUR |
| LS Exchange:A2AG6H | LS Exchange | Germany | EUR |
| BOATS:NTLA | BOATS | United States | USD |
| Tradegate:38I | Tradegate | Germany | EUR |
| Lang & Schwarz:A2AG6H | Lang & Schwarz | Germany | EUR |
| Hamburg:38I | Hamburg | Germany | EUR |
| LSE:0JBU | LSE | United Kingdom | USD |
| Frankfurt:38I | Frankfurt | Germany | EUR |
| Stuttgart:38I | Stuttgart | Germany | EUR |
| BX Swiss:38I | BX Swiss | Switzerland | CHF |
| Dusseldorf:38I | Dusseldorf | Germany | EUR |
| Munich:38I | Munich | Germany | EUR |
| Hanover:38I | Hanover | Germany | EUR |
| Xetra:38I | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Intellia Therapeutics, Inc.